Colorectal Carcinoma
240
48
74
106
Key Insights
Highlights
Success Rate
80% trial completion
Published Results
43 trials with published results (18%)
Research Maturity
106 completed trials (44% of total)
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 59/100
11.3%
27 terminated out of 240 trials
79.7%
-6.8% vs benchmark
7%
17 trials in Phase 3/4
41%
43 of 106 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 106 completed trials
Clinical Trials (240)
Vaccine Therapy in Treating Patients With Newly Diagnosed Advanced Colon Polyps
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
Neoantigen Dendritic Cell Vaccine and Nivolumab in HCC and Liver Metastases From CRC
The Cancer Connected Access and Remote Expertise Beyond Walls Program to Provide In-Home Cancer Treatment and Improve Treatment Satisfaction in Cancer Patients Living in the Florida Panhandle and Surrounding Areas
Phase 1 Study to Investigate TCRTs KRAS Mutation in Unresectable, Advanced, and/or Metastatic Solid Tumors
COLORECTUM+ Digital System for Postoperative Quality Improvement in Colorectal Cancer
ABCSG C08-Exercise II: Trial of Endurance Exercise Following Adjuvant Chemotherapy for Colorectal Cancer
Immune Response Activation for the Treatment of Unresectable Metastatic Colorectal Cancer or CEA Positive Metastatic Breast Cancer
Assessment of Current Biomarker Testing Practices for Common Solid Cancers in Precision Oncology in the Community Setting
CoGENES Randomized Controlled Trial (RCT)
A Study of NT-175 in Adult Participants With Advanced Malignancies That Are Positive for HLA-A*02:01 and the TP53 R175H Mutation
A Phase 1 Study of Pegilodecakin (LY3500518) in Participants With Advanced Solid Tumors
The Vanguard Study: Testing a New Way to Screen for Cancer
An Investigational Drug (TPST-1495) in Patients With Familial Adenomatous Polyposis
Determining the Biodistribution of an Imaging Tracer (68Ga-FAPi-46) in Patients With Solid Tumors or Hematologic Cancers
Culturally Adapting an Intervention to Increase Genetic Testing in African American Cancer Survivors
A Multilevel Intervention to Increase Colorectal Cancer Screening Tests in Patients With Abnormal Fecal Immunochemical Test Results, PROACT Trial
Testing a Combination of Vaccines for Cancer Prevention in Lynch Syndrome
Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies
A Dietary Intervention (Soy Soft Pretzels) for Reducing Chronic Inflammation in Obese Individuals